Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Chemistry & Biology|July 3, 2003
The platelet as a model for chemical geneticsRobert Flaumenhaft, Derek S SimHandbook of Experimental Pharmacology|November 11, 2015
In Vivo Target Validation Using Biological Molecules in Drug DevelopmentDerek S Sim, Katalin KauserHematology (Amsterdam, Netherlands)|December 3, 2005
Protein palmitoylation in signal transduction of hematopoietic cellsRobert Flaumenhaft, Derek S SimBiomarker Insights|July 7, 2009
Biomarkers and Bioassays for Cardiovascular Diseases: Present and FutureDerek S Sim, Hsiao Lieu, Patrick AndreArteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formationDerek S Sim, James R Dilks, Robert FlaumenhaftThe Journal of Trauma and Acute Care Surgery|June 19, 2023
Rapid clearing CT-001 restored hemostasis in mice with coagulopathy induced by activated protein CDerek S Sim, Cornell R Mallari, Maxine Bauzon, et al.Blood Cells, Molecules & Diseases|April 25, 2006
Blood cells as targets of snake toxinsXiao-Yan Du, Derek S Sim, Wen-Hui Lee, et al.Blood|December 3, 2003
Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levelsDerek S Sim, Glenn Merrill-Skoloff, Barbara C Furie, et al.Thrombosis Research|May 31, 2022
CT-001 is a rapid clearing factor VIIa with enhanced clearance and hemostatic activity for the treatment of acute bleeding in non-hemophilia settingsDerek S Sim, Cornell R Mallari, John M Teare, et al.Research and Practice in Thrombosis and Haemostasis|July 15, 2021
In vitro characterization of CT-001-a short-acting factor VIIa with enhanced prohemostatic activityDerek S Sim, Cornell R Mallari, John M Teare, et al.Pageof 2